The global enteric softgel capsules market is poised for significant growth, according to recent research by Future Market Insights. The market, valued at USD 305.3 million in 2023, is projected to expand at a robust compound annual growth rate (CAGR) of 6.7%, reaching a value of USD 582.5 million by 2033.
In 2022, the enteric softgel capsules market stood at USD 288.8 million, and it is set to experience a steady Year-over-Year (Y-o-Y) growth of 5.7% in 2023. The rising demand for softgel capsules in the pharmaceutical, nutraceutical, and dietary supplement industries is driving this growth.
Enteric softgel capsules are gaining popularity due to their ability to protect sensitive ingredients from stomach acids, ensuring optimal release in the intestine. This makes them an ideal choice for delivering active ingredients like vitamins, probiotics, and other health supplements. With increasing consumer awareness of health and wellness, the demand for enteric softgel capsules is expected to rise across multiple markets, contributing to the overall growth of the industry.
This market expansion is also supported by advancements in capsule formulation technology, which are enhancing the bioavailability and effectiveness of active ingredients. Manufacturers are investing in innovative solutions to cater to the growing demand for personalized health products, further driving market growth.
The global enteric softgel capsules market is expected to remain on an upward trajectory through 2033, offering significant opportunities for stakeholders across the pharmaceutical and nutraceutical industries.
Key Takeaways from Market Study:
- By product, gelatin softgel capsules segment contributed around USD 214.7 million in 2022. Gelatin softgel capsules are the most popular due to their widespread acceptability, ease of formulation, and well-established production techniques.
- By raw material, type-A gelatin (pork skin) contributed around USD 123.8 million in 2022. Due to its ample supply, compatibility with enteric coatings, and established manufacturing procedures, type-A gelatin (pig skin) dominates the global market.
- By application segment, vitamin and dietary supplements segment contributed around USD 96.1 million in 2022, Due to rising customer demand for tailored nutritional delivery and better absorption, the Vitamin and Dietary Supplements industry leads.
- By end user, pharmaceutical companies contributed around USD 97.1 million in 2022. Demand is driven by pharmaceutical companies’ research and development skills, as well as the necessity for effective medication delivery methods.
- By region, North America held the dominant share in the world in 2022 contributing around USD 92.6 Million. North America leads due to advanced healthcare infrastructure, increased spending on research and development, and a thriving pharmaceutical sector, which fuels demand for new medication delivery.
“Increasing incidence of gastrointestinal disorders and growing demand for effective treatment options to boost the market for enteric softgel capsules” says an analyst of Future Market Insights.
Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!
Market Competition
GELITA AG and Sirio Pharma Co Ltd are two of the key players leading in the enteric softgel capsules market. In order to gain a larger market share, these companies participate in conferences, award competitions, and launch new products that provide affordability, convenience, and effectiveness.
- In July 2022, GELITA AG has established a biotechnology facility in Frankfurt am Main that will focus on protein development for nutrition, cosmetics, and pharmaceutical products. This investment is a significant step forward in GELITA’s drive toward a sustainable product portfolio.
- On April 2019, Sirio’s Ayanda launches probiotic softgel
Key Companies Profiled:
- GELITA AG
- Catalent Inc
- Renown Pharmaceuticals Pvt. Ltd.
- InovoBiologic Inc
- Viva Pharmaceutical,
- Aenova Group
- Basf Se
- Lonza Group Ltd
- Procaps Laboratory
- Sirio Pharma Co Ltd.
Key Market Segments Covered in Enteric Softgel Capsules Industry Research
By Product:
- Gelatin Softgel Capsules
- Vegetarian Softgel Capsules
By Raw Material:
- Type-A Gelatin (Pork Skin)
- Type-B Gelatin (Animal Bones and Skin)
- Fish Bone Gelatin
- Cellulose Derivatives
- Starch Material
By Application:
- Antacid and Antiflatulent Preparations
- Anti-inflammatory Drugs
- Antibiotic and Antibacterial Drugs
- Cough and Cold Preparations
- Health Supplements
- Vitamin and Dietary Supplements
- Other Therapeutic Applications
By End User:
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Food Industry
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
